| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0005 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.19 | 0.0006 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 0.0006 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0009 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |